This case study highlights how implementing CylancePROTECT benefited a high-profile financial institution in the US.
- 400 locations
- 10,000 endpoints
- 1.3 million patients
- Reduce the number and severity of malware outbreaks
- Prevent theft of personally identifiable information
- Protect sensitive research and development information
- Assess vulnerabilities in medical devices produced by the company
- Safeguard 1.3 million patient records and comply with HIPAA regulations
- Deploy CylancePROTECT® to 10,000 endpoints
- Compromise Assessment service to identify if a breach occurred
- Penetration Test of medical devices and supporting infrastructure
A US-based healthcare services and product provider with over 400 locations nationwide, directly supporting over one million patients.
Despite investing heavily in their cybersecurity infrastructure, the company routinely responded to malware outbreaks. By adopting a “detect and respond” approach, the company’s IT department and security budgets were funneled into acquiring network-based detection products and chasing threats after the damage had already been done. As a large medical services and product provider, the company could not risk losing patient data or being exposed to any regulation violations.
The company’s CIO decided to focus on preventive endpoint malware detection as a fundamental shift in their approach to mitigating future risks. After comparing several next-generation endpoint security products, CylancePROTECT was brought in for a pilot program.
After a successful Proof Of Concept (POC) with 250 endpoints, CylancePROTECT was deployed enterprise-wide to augment their existing endpoint security technologies. Immediately, CylancePROTECT detected and blocked three types of custom-designed malware specifically targeting their organization as well as hundreds of potentially unwanted programs (PUP) that are routinely used to assist hackers in data exfiltration.
All of their existing security solutions completely missed detecting these files.
POC deployments of 30 days are common, but in this instance, the company moved forward with a full purchase of CylancePROTECT after just two weeks. The company then removed their active AV solution, as well as their Host Intrusion Prevention Systems (HIPS) products from over 9,000 endpoints. This freed up system resources and reduced end-user impact, which are common challenges for traditional endpoint solutions.
The company then engaged the Cylance Consulting team to assist in the remediation and investigation of incidents stemming from the prior malware outbreaks. At the end of the engagement, the company had zero malware or PUP infections.
The company realized additional benefits, beyond their core goal of increased malware protection, in the form of lower performance impact to each endpoint and the monetary benefit of consolidating their antivirus and HIPS solutions.
“CylancePROTECT works more effectively and efficiently than any other endpoint protection solution we evaluated. On top of that, it requires less effort to manage. Switching to Cylance has improved our company’s security position without disrupting end-user workflow.”
-Security Manager, Healthcare Company